These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25714613)

  • 1. The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases.
    Sheng J; Chen W; Zhu HJ
    Growth Factors; 2015 Apr; 33(2):92-101. PubMed ID: 25714613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.
    Sanjabi S; Oh SA; Li MO
    Cold Spring Harb Perspect Biol; 2017 Jun; 9(6):. PubMed ID: 28108486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity.
    Fousteri G; Liossis SN; Battaglia M
    Clin Immunol; 2013 Dec; 149(3):556-65. PubMed ID: 24269925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Kriegel MA; Li MO; Sanjabi S; Wan YY; Flavell RA
    Curr Rheumatol Rep; 2006 Apr; 8(2):138-44. PubMed ID: 16569373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta regulation of immune responses.
    Li MO; Wan YY; Sanjabi S; Robertson AK; Flavell RA
    Annu Rev Immunol; 2006; 24():99-146. PubMed ID: 16551245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
    Huang XL; Zhang L; Li JP; Wang YJ; Duan Y; Wang J
    Autoimmunity; 2015; 48(8):503-10. PubMed ID: 26287504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of TGF-beta signaling in dendritic cell tolerance.
    Esebanmen GE; Langridge WHR
    Immunol Res; 2017 Oct; 65(5):987-994. PubMed ID: 28845509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.
    Laouar Y; Sutterwala FS; Gorelik L; Flavell RA
    Nat Immunol; 2005 Jun; 6(6):600-7. PubMed ID: 15852008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming Growth Factor-β Signaling in Immunity and Cancer.
    Batlle E; Massagué J
    Immunity; 2019 Apr; 50(4):924-940. PubMed ID: 30995507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotransfection with IL-10 and TGF-β1 into immature dendritic cells enhances immune tolerance in a rat liver transplantation model.
    Chen L; Zheng L; He W; Qiu M; Gao L; Liu J; Huang A
    Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G575-81. PubMed ID: 24503768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppressive function of human CD8(+) iTregs is inhibited by IL-1β and TNFα.
    Bjarnadottir U; Lemarquis AL; Halldorsdottir S; Freysdottir J; Ludviksson BR
    Scand J Immunol; 2014 Nov; 80(5):313-22. PubMed ID: 25039313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TGF-β superfamily in dendritic cell biology.
    Seeger P; Musso T; Sozzani S
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):647-57. PubMed ID: 26115564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
    Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
    J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22.
    Rekik R; Smiti Khanfir M; Larbi T; Zamali I; Beldi-Ferchiou A; Kammoun O; Marzouki S; Hamzaoui S; Mrad S; Barbouche MR; Houman MH; Ben Ahmed M
    Cytokine; 2018 Aug; 108():182-189. PubMed ID: 29684755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
    Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
    Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.